DC Circ. Won't Rehear Med Tech Co.'s $400M Award Denial
The D.C. Circuit on Tuesday denied a medical technology company's bid for a rehearing en banc after a panel affirmed a lower court decision to reject a $400 million arbitral award...To view the full article, register now.
Already a subscriber? Click here to view full article